近日，中山大学材料科学与工程学院陈永明、刘利新教授团队在国际上第一次阐明了聚合多肽抑制NA激活TLR9的机制，原创性研究论文以 “Synthetic polypeptides inhibit nucleic acid-induced inflammation in autoimmune diseases by disrupting multivalent TLR9 binding to ...

"GSK reports positive interim data from mRNA influenza vaccine trial" was originally created and published by Clinical Trials ...

Synthetic polypeptides inhibit nucleic acid-induced inflammation in autoimmune diseases by disrupting multivalent TLR9 binding to LL37-DNA bundles 的研究论文。 该研究通过合成多肽 ...

The MRC director, Prof Moffat Nyirenda, said the study offers Ugandan scientists opportunities to showcase their capabilities ...

TFF Pharmaceuticals Inc. has announced promising preclinical data advancing a multivalent universal influenza vaccine manufactured by its Thin Film Freezing (TFF) technology to protect against ...

A drive to overcome the limitations of traditional antibodies led Toronto-based scientists Jean-Philippe Julien and Bebhinn Treanor to work toward discovering a multivalent, multispecific platform to ...

Valneva and Pfizer have reported positive data from a Phase II trial of a second booster dose of their Lyme disease vaccine ...

GSK has shared positive headline results for its mRNA seasonal influenza vaccine and outlined that it will now progress the ...

Thursday announced positive data from a phase II trial for its mRNA seasonal influenza vaccine programme. The study ...

GSK announces positive headline data from phase II seasonal influenza mRNA vaccine programme: London, UK Friday, September 13, 2024, 11:00 Hrs [IST] GSK plc announced positive hea ...